These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5936177)

  • 1. Turnover of 131-I-labelled fibrinogen in man. Studies in normal subjects, in congenital coagulation factor deficiency states, in liver cirrhosis, in polycythemia vera and in epidermolysis bullosa.
    Blombäck B; Carlson LA; Franzén S; Zetterqvist E
    Acta Med Scand; 1966 May; 179(5):557-74. PubMed ID: 5936177
    [No Abstract]   [Full Text] [Related]  

  • 2. Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
    Zetterqvist E
    Acta Physiol Scand Suppl; 1969; 325():1-41. PubMed ID: 4900570
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of fibrinogen in cirrhosis of the liver.
    Tytgat GN; Collen D; Verstraete M
    South Med J; 1971 Oct; 64(10):1690-701. PubMed ID: 5125556
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of fibrinogen in cirrhosis of the liver.
    Tytgat GN; Collen D; Verstraete M
    J Clin Invest; 1971 Aug; 50(8):1690-701. PubMed ID: 5163179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 125I fibrinogen turnover in polycythaemia: the effect of phlebotomy.
    Boughton BJ; Dallinger KJ
    Br J Haematol; 1983 Jan; 53(1):97-102. PubMed ID: 6848130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolism and localization of I 131-fibrinogen in chronic intravascular coagulation].
    Straub PW; Kessler S
    Schweiz Med Wochenschr; 1970 Nov; 100(46):2001-3. PubMed ID: 5507850
    [No Abstract]   [Full Text] [Related]  

  • 7. [Incorporation of I-125 labelled fibrinogen. Study in normal subjects].
    Langer B; Camargo EE; Mário J; dos Reis M; Carvalho N; Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1976; 31(2):99-104. PubMed ID: 1265379
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE ERYTHREMIC INDEX. SIGNIFICANT CHANGES DUE TO A COAGULATION DISORDER IN POLYCYTHEMIA].
    MATCHABELI M
    Hemostase; 1965 Mar; 5():47-53. PubMed ID: 14346513
    [No Abstract]   [Full Text] [Related]  

  • 9. TURNOVER AND DISTRIBUTION OF 131-IODINE-LABELLED HUMAN FIBRINOGEN.
    AMRIS A; AMRIS CJ
    Thromb Diath Haemorrh; 1964 Jul; 11():404-22. PubMed ID: 14191721
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on hypercoagulable state. II. The application of 131I-labelled fibrinogen for the estimation of intravascular coagulation in human subjects.
    Izak G; Galewski K; Eyal Z
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):544-51. PubMed ID: 5590243
    [No Abstract]   [Full Text] [Related]  

  • 11. Organ distribution of fibrin in disseminated intravascular coagulation.
    Regoeczi E; Brain MC
    Br J Haematol; 1969 Jul; 17(1):73-81. PubMed ID: 5807789
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in hemostasis during polycythemia vera (review and personal contribution)].
    Tucci G; Facchini G; Spagna I; Masiello O; Cremonini GP
    Arch Patol Clin Med; 1968 Nov; 45(1):3-29. PubMed ID: 5737487
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood coagulation changes in splenic diseases].
    Askherkhanov RP; Safarov SIu
    Vestn Khir Im I I Grek; 1972 Apr; 108(4):65-71. PubMed ID: 5070609
    [No Abstract]   [Full Text] [Related]  

  • 14. BLOOD COAGULATION IN EPIDERMOLYSIS BULLOSA HEREDITARIA. GENETIC OBSERVATIONS.
    TIO TH; WAARDENBURG PJ; VERMEULEN HJ
    Arch Dermatol; 1963 Jul; 88():24-31. PubMed ID: 14042658
    [No Abstract]   [Full Text] [Related]  

  • 15. Haptoglobin metabolism in polycythemia vera.
    Krauss S
    Blood; 1969 Jun; 33(6):865-76. PubMed ID: 5795764
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental hepatic necrosis: studies on coagulation abnormalities, plasma clearance, and organ distribution of 125I-labelled fibrinogen.
    Rake MO; Flute PT; Pannell G; Shilkin KB; Williams R
    Gut; 1973 Jul; 14(7):574-80. PubMed ID: 4729927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism of fibrinogen in the cirrhotic patient. Dynamic study by isotope method].
    Delmont J; Bisset J; Rampal P; Camous JP; Faure X
    Nouv Presse Med; 1976 Jun; 5(25):1567-9. PubMed ID: 934880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
    Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution and turnover of fibrinogen labelled with I-125 in atherosclerotic subjects].
    Cajozzo A; Indovina I; Carreca I
    Haematologica; 1971; 56(11):479-87. PubMed ID: 5004756
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nutritional condition of epidermolysis bullosa patients assessed from body height and weight].
    Ikeda S; Manabe M; Ogawa H; Inaba Y
    Nihon Hifuka Gakkai Zasshi; 1990 Jun; 100(7):805-9. PubMed ID: 2214244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.